INSM Q2 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M+17.0% YoY

Gross Profit

$69M76.8% margin

Operating Income

-$289M-319.8% margin

Net Income

-$301M-332.8% margin

EPS (Diluted)

$-1.94

QoQ Revenue Growth

+19.7%

Cash Flow

Operating Cash Flow

-$123M

Free Cash Flow

-$130M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.8B

Stockholders' Equity

$39M

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$77M	+17.0%
Gross Profit	$69M	$61M	+14.4%
Operating Income	-$289M	-$236M	-22.7%
Net Income	-$301M	-$245M	-22.8%

Geographic Segments

UNITED STATES

$64M71%

JAPAN

$21M23%

Europe And The Rest Of The World

$5M6%